- Yonsei University and Health System Co-Host 'Advanced Cancer Therapeutics Summit 2024' June 13, 2024
-
Participation from Harvard University, Columbia University, Mayo Clinic, and Pharmaceutical Industry
[Photo 1. From left to right: Ki Chang Keum, Senior Vice President for Medical Affairs, President Dong-Sup Yoon, Anil K. Rustgi, Director of the Herbert Irving Comprehensive Cancer Center at Columbia University, Jae Ho Cheong, Director of the YSP Promotion Headquarters, and Jongsoo Lee, Senior Vice President of International Campus]
On June 1-2, Yonsei University and Yonsei University Health System hosted the 'Advanced Cancer Therapeutics Summit (ACTS) 2024.'
The symposium was held at the Yonsei Museum and Garden of Yonsei(Gwanghyewon), home to the reconstructed Gwanghye Hospital(광혜원, 廣惠院), the origin of modern medicine in Korea. The event was organized under the vision "Yonsei: Opening Human Possibilities with Truth and Freedom," declared on the 139th anniversary of Yonsei's founding in May.
The event focused on interdisciplinary convergence and the establishment of a global convergence network through international exchanges. Various strategies were discussed to advance Yonsei University's vision. Leading scholars and researchers from the world's top institutions, engaged in developing new cancer therapies, were invited to share their latest insights and to foster collaboration with the domestic industry aiming to pioneer next-generation drug markets.
[Photo 2. Group photo from the opening ceremony]During the opening ceremony, Yonsei University and Yonsei University Health System signed a Memorandum of Understanding (MOU) with the Herbert Irving Comprehensive Cancer Center at Columbia University. Under this agreement, Yonsei University and the Health System will utilize their excellent clinical infrastructure and capabilities to collaborate on global clinical trials specializing in solid tumors and gastrointestinal cancers. Additionally, they agreed to establish the Columbia-Yonsei AI Research Center (tentative name) on the International Campus to facilitate cooperation with the planned Gastrointestinal Cancer Research Center at Columbia University's New York Campus.
Prominent speakers included Professor William R. Sellers of Harvard Medical School, who previously led global cancer research at Novartis, and Dr. Anil K. Rustgi, a world-renowned expert in gastrointestinal cancers and former president of the International Society for Gastrointestinal Oncology, currently serving as the director of the Herbert Irving Comprehensive Cancer Center at Columbia University. They shared global perspectives and trends in cancer treatment. Over 100 industry experts from leading domestic pharmaceutical and biotech companies, bio-ventures, investment institutions, and academia attended the event. They discussed research outcomes centered on cell and gene therapy, which has been designated as a key strategic technology for Korea's advanced bio-industry, and explored collaboration with the invited researchers.
President Dong-Sup Yoon stated, "Yonsei University aims to present a future university model where the knowledge and assets of the university are utilized to drive societal development, and the generated social value is reinvested into the university." He further emphasized, "We will spare no effort in supporting the development and activation of the industry-academia-research-hospital cooperation model."
-
SINCHON·INT′l
SINCHON·INT′l
- MIRAE
show mobile menu
mobile menu
